Ceftolozane/tazobactam

Kathryn Dzintars, Pharm.D., BCPS
Pediatric Dosing Author: Lisa Hutchins, Pharm.D.
Ceftolozane/tazobactam is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please log in or purchase a subscription.

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

Pediatrics Central

Abdominal MassAbdominal Mass

metoprololmetoprolol

Hepatic AbscessHepatic Abscess

Inguinal HerniaInguinal Hernia

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Complicated intra-abdominal infections (cIAI), used in combination with metronidazole
  • Complicated urinary tract infections (cUTI), including pyelonephritis
  • Hospital-acquired bacterial and ventilator-associated pneumonia (VAP)

Note: FDA indications for age ≥ 18 yrs

NON-FDA APPROVED USES

  • Pseudomonas aeruginosa infections (including some MDR isolates, limited data[4])

-- To view the remaining sections of this topic, please log in or purchase a subscription --

INDICATIONS

FDA

  • Complicated intra-abdominal infections (cIAI), used in combination with metronidazole
  • Complicated urinary tract infections (cUTI), including pyelonephritis
  • Hospital-acquired bacterial and ventilator-associated pneumonia (VAP)

Note: FDA indications for age ≥ 18 yrs

NON-FDA APPROVED USES

  • Pseudomonas aeruginosa infections (including some MDR isolates, limited data[4])

There's more to see -- the rest of this entry is available only to subscribers.